Adaptive Pathways Archives - The Office of Health Economics (OHE)

Search the Knowledge Hub

The future of comparative effectiveness and relative efficacy of drugs: an international perspective

Donna A Messner, Adrian Towse, Penny Mohr, Martina Garau

Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What is Different About a One-Off Treatment?

Adrian Towse and Elisabeth Fenwick

Why are Patients in Need Not Getting Early Access to Life-Changing Medicines?

Hannah Schirrmacher, Isobel Firth and Grace Hampson

Making Outcome-Based Payment a Reality in the NHS

Cole, A., Cubi-Molla, P., Pollard, J., Sim, D., Sullivan, R., Sussex, J. and Lorgelly, P.

Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies

Firth, I., Schirrmacher, H., Hampson, G. and Towse, A.

Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK

Bernarda Zamora

How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

Cole, A., Chan, A., Mujoomdar, M., Pichler, F. and Towse, A.

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?

Marsden, G. and Towse, A.

Economics of Innovative Payment Models Compared with Single Pricing of Pharmaceuticals

Cole, A., Towse, A., Lorgelly, P., and Sullivan, R.

Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries

Zamora, B., Maignen, F., O’Neill, P., Mestre-Ferrandiz, J. and Garau, M.

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments

Marina Rodes Sanchez, Nadine Henderson and Lotte Steuten

Get Technical Assistance